Jeffrey N. Simmons - 01 Mar 2023 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role: PRESIDENT, CEO AND DIRECTOR, Director
Signature: /s/ Catherine S. Powell, as Attorney-in-Fact for Jeffrey N. Simmons
Issuer symbol: ELAN
Transactions as of: 01 Mar 2023
Net transactions value: -$243,305
Form type: 4
Filing time: 03 Mar 2023, 20:10:40 UTC
Previous filing: 09 Sep 2022
Next filing: 06 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELAN	Common Stock	Tax liability	$142,574	-12,662	-1.7%	$11.26	742,369	01 Mar 2023	Direct	F1, F2
transaction	ELAN	Common Stock	Award	$0	+248,668	+33%	$0.000000	991,037	01 Mar 2023	Direct	F3
transaction	ELAN	Common Stock	Tax liability	$100,730	-9,149	-0.93%	$11.01	974,761	02 Mar 2023	Direct	F1, F4
holding	ELAN	Common Stock						30,000	01 Mar 2023	Revocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELAN	Employee Stock Option (right to buy)	Award	$0	+567,952		$0.000000	567,952	01 Mar 2023	Common Stock	567,952	$11.26	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan.
F2	Includes 2,045 shares acquired under Elanco Animal Health Inc.'s Employee Stock Purchase Plan on December 30, 2022.
F3	Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2023, one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026.
F4	Balance reflects 7,127 fewer shares due to an error in the number of shares previously reported as forfeited in a prior Form 4.
F5	Grant of stock options vesting as follows: one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026.